Clinical trial

Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patients

NCT02946671

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-03-01

PhasePHASE1

Study timeline

Study start (unknown)2016-03-01Date precision: month

Registry last updated2020-03-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Gastric Cancerunresolved

Esophageal Cancerunresolved

Lung Cancerunresolved

Renal Cancerunresolved

Oral Cancerunresolved

Interventions

MogamulizumabBIOLOGICAL

NivolumabBIOLOGICAL

Sponsors & collaborators

Osaka Universitylead sponsor

Kyowa Kirin Co., Ltd.collaborator

Ono Pharmaceutical Co., Ltd.collaborator

Clinical Study Support, Inc.collaborator

Fiverings Co., Ltd.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02946671 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.